Process View
Any process that modulates the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of extrinsic apoptotic signaling pathway via death domain receptors"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.999 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.969 | ||
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.748 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 0.712 | ||
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.605 | ||
| FGA | fibrinogen alpha chain | 0.591 | ||
| TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.500 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.450 | ||
| TGIF1 | TGFB-induced factor homeobox 1 | 0.370 | ||
| SNAP23 | synaptosomal-associated protein, 23kDa | 0.364 | ||
| TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 | 0.330 | ||
| BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.328 | ||
| PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0.305 | ||
| PLAU | plasminogen activator, urokinase | 0.289 | ||
| FGB | fibrinogen beta chain | 0.283 | ||
| STK3 | serine/threonine kinase 3 | 0.216 | Mouse | |
| STRN | striatin, calmodulin binding protein | 0.182 | ||
| VAMP3 | vesicle-associated membrane protein 3 (cellubrevin) | 0.167 | ||
| ITGAL | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | 0.153 | ||
| NAPA | N-ethylmaleimide-sensitive factor attachment protein, alpha | 0.149 | ||
| FTL | ferritin, light polypeptide | 0.137 | ||
| VIM | vimentin | 0.135 | ||
| FN1 | fibronectin 1 | 0.123 | ||
| SNAP25 | synaptosomal-associated protein, 25kDa | 0.120 | ||
| CASP8AP2 | caspase 8 associated protein 2 | 0.119 | ||
| FGG | fibrinogen gamma chain | 0.095 | ||
| SP100 | SP100 nuclear antigen | 0.092 | ||
| MAPK1 | mitogen-activated protein kinase 1 | 0.088 | ||
| LRP1 | low density lipoprotein receptor-related protein 1 | 0.083 | ||
| CALCOCO2 | calcium binding and coiled-coil domain 2 | 0.074 | ||
| PLAT | plasminogen activator, tissue | 0.070 | ||
| BCL2 | B-cell CLL/lymphoma 2 | 0.070 | ||
| MAP2K1 | mitogen-activated protein kinase kinase 1 | 0.066 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.063 | ||
| STK4 | serine/threonine kinase 4 | 0.056 | Mouse | |
| PPM1F | protein phosphatase, Mg2+/Mn2+ dependent, 1F | 0.055 | ||
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.055 | ||
| CRADD | CASP2 and RIPK1 domain containing adaptor with death domain | 0.055 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.054 | ||
| FADD | Fas (TNFRSF6)-associated via death domain | 0.051 | Mouse | |
| CA12 | carbonic anhydrase XII | 0.050 | ||
| UROD | uroporphyrinogen decarboxylase | 0.050 | ||
| TP53BP2 | tumor protein p53 binding protein, 2 | 0.050 | ||
| BID | BH3 interacting domain death agonist | 0.050 | ||
| PTPRC | protein tyrosine phosphatase, receptor type, C | 0.049 | ||
| BAD | BCL2-associated agonist of cell death | 0.046 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.045 | ||
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.042 | ||
| FHL2 | four and a half LIM domains 2 | 0.041 | ||
| FBN1 | fibrillin 1 | 0.041 | ||
| EMP3 | epithelial membrane protein 3 | 0.040 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.039 | ||
| PLEK | pleckstrin | 0.038 | ||
| MICA | MHC class I polypeptide-related sequence A | 0.038 | ||
| GBP1 | guanylate binding protein 1, interferon-inducible | 0.038 | ||
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.038 | ||
| IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.037 | ||
| CRP | C-reactive protein, pentraxin-related | 0.037 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.036 | ||
| BCL2L1 | BCL2-like 1 | 0.034 | ||
| BAX | BCL2-associated X protein | 0.034 | ||
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.034 | ||
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.033 | ||
| S100A10 | S100 calcium binding protein A10 | 0.033 | ||
| ATXN3 | ataxin 3 | 0.032 | ||
| TNIP1 | TNFAIP3 interacting protein 1 | 0.032 | ||
| RASSF3 | Ras association (RalGDS/AF-6) domain family member 3 | 0.032 | ||
| SRI | sorcin | 0.030 | ||
| PPP2CA | protein phosphatase 2, catalytic subunit, alpha isozyme | 0.030 | ||
| SAMD9 | sterile alpha motif domain containing 9 | 0.029 | ||
| CIB1 | calcium and integrin binding 1 (calmyrin) | 0.029 | ||
| NMI | N-myc (and STAT) interactor | 0.028 | ||
| CASP2 | caspase 2, apoptosis-related cysteine peptidase | 0.025 | ||
| CASP1 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 0.025 | ||
| GDF5 | growth differentiation factor 5 | 0.024 | ||
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.024 | ||
| PSEN1 | presenilin 1 | 0.024 | ||
| CASP4 | caspase 4, apoptosis-related cysteine peptidase | 0.023 | ||
| TRIM38 | tripartite motif containing 38 | 0.023 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.022 | ||
| FAM190B | family with sequence similarity 190, member B | 0.022 | ||
| TMSB4X | thymosin beta 4, X-linked | 0.021 | ||
| TRAF6 | TNF receptor-associated factor 6 | 0.021 | ||
| BBC3 | BCL2 binding component 3 | 0.019 | ||
| COL6A2 | collagen, type VI, alpha 2 | 0.019 | ||
| CARD11 | caspase recruitment domain family, member 11 | 0.019 | ||
| RNF4 | ring finger protein 4 | 0.019 | ||
| BIK | BCL2-interacting killer (apoptosis-inducing) | 0.019 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.018 | ||
| TMC6 | transmembrane channel-like 6 | 0.018 | Human | |
| DOCK7 | dedicator of cytokinesis 7 | 0.018 | ||
| BECN1 | beclin 1, autophagy related | 0.018 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.018 | ||
| ORM1 | orosomucoid 1 | 0.018 | ||
| BAK1 | BCL2-antagonist/killer 1 | 0.018 | ||
| USP15 | ubiquitin specific peptidase 15 | 0.018 | ||
| TRADD | TNFRSF1A-associated via death domain | 0.018 | ||
| ETS1 | v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) | 0.017 | ||
| LATS2 | LATS, large tumor suppressor, homolog 2 (Drosophila) | 0.017 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.017 | ||
| IFI16 | interferon, gamma-inducible protein 16 | 0.017 | ||
| OSMR | oncostatin M receptor | 0.017 | ||
| MAPK3 | mitogen-activated protein kinase 3 | 0.017 | ||
| ITGB1BP1 | integrin beta 1 binding protein 1 | 0.016 | ||
| TUBB6 | tubulin, beta 6 | 0.016 | ||
| IL8 | interleukin 8 | 0.016 | ||
| TMC8 | transmembrane channel-like 8 | 0.016 | ||
| VPS13D | vacuolar protein sorting 13 homolog D (S. cerevisiae) | 0.016 | ||
| SOD1 | superoxide dismutase 1, soluble | 0.016 | ||
| HSD3B7 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 | 0.016 | ||
| DUSP3 | dual specificity phosphatase 3 | 0.016 | ||
| CD44 | CD44 molecule (Indian blood group) | 0.016 | ||
| RARRES2 | retinoic acid receptor responder (tazarotene induced) 2 | 0.016 | ||
| F2 | coagulation factor II (thrombin) | 0.016 | ||
| S100A11 | S100 calcium binding protein A11 | 0.015 | ||
| TMSB10 | thymosin beta 10 | 0.015 | ||
| MYD88 | myeloid differentiation primary response gene (88) | 0.015 | ||
| PPP1R14A | protein phosphatase 1, regulatory (inhibitor) subunit 14A | 0.015 | ||
| C1orf38 | chromosome 1 open reading frame 38 | 0.015 | ||
| PEBP4 | phosphatidylethanolamine-binding protein 4 | 0.015 | ||
| XAF1 | XIAP associated factor 1 | 0.015 | ||
| SAV1 | salvador homolog 1 (Drosophila) | 0.015 | ||
| SPSB1 | splA/ryanodine receptor domain and SOCS box containing 1 | 0.015 | ||
| ANXA1 | annexin A1 | 0.015 | ||
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.015 | ||
| NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.014 | ||
| SP140L | SP140 nuclear body protein-like | 0.014 | Human | |
| SFRP4 | secreted frizzled-related protein 4 | 0.014 | ||
| SQSTM1 | sequestosome 1 | 0.014 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.014 | ||
| FLNB | filamin B, beta | 0.014 | ||
| TSPO | translocator protein (18kDa) | 0.014 | ||
| AEBP1 | AE binding protein 1 | 0.014 | ||
| CSNK1A1 | casein kinase 1, alpha 1 | 0.014 | ||
| PECAM1 | platelet/endothelial cell adhesion molecule | 0.014 | ||
| OAZ1 | ornithine decarboxylase antizyme 1 | 0.013 | ||
| RRAS | related RAS viral (r-ras) oncogene homolog | 0.013 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.013 | ||
| ITGB5 | integrin, beta 5 | 0.013 | ||
| EFEMP2 | EGF containing fibulin-like extracellular matrix protein 2 | 0.013 | ||
| RASSF2 | Ras association (RalGDS/AF-6) domain family member 2 | 0.013 | ||
| IRF1 | interferon regulatory factor 1 | 0.013 | ||
| RASSF5 | Ras association (RalGDS/AF-6) domain family member 5 | 0.013 | ||
| APOA1 | apolipoprotein A-I | 0.013 | ||
| HMGN2 | high mobility group nucleosomal binding domain 2 | 0.013 | ||
| TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.013 | ||
| WIPI1 | WD repeat domain, phosphoinositide interacting 1 | 0.013 | ||
| TNF | tumor necrosis factor | 0.013 | ||
| DDB2 | damage-specific DNA binding protein 2, 48kDa | 0.013 | ||
| USP4 | ubiquitin specific peptidase 4 (proto-oncogene) | 0.012 | ||
| ADAR | adenosine deaminase, RNA-specific | 0.012 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.012 | ||
| TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.012 | ||
| TNIP2 | TNFAIP3 interacting protein 2 | 0.012 | ||
| CCND2 | cyclin D2 | 0.012 | ||
| ENG | endoglin | 0.012 | ||
| MALT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | 0.012 | ||
| MSN | moesin | 0.012 | ||
| RHEB | Ras homolog enriched in brain | 0.012 | ||
| SPHK1 | sphingosine kinase 1 | 0.012 | ||
| ASPN | asporin | 0.012 | ||
| STAM | signal transducing adaptor molecule (SH3 domain and ITAM motif) 1 | 0.012 | ||
| IER3 | immediate early response 3 | 0.012 | ||
| DUSP5 | dual specificity phosphatase 5 | 0.012 | ||
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.011 | ||
| CCND1 | cyclin D1 | 0.011 | ||
| THY1 | Thy-1 cell surface antigen | 0.011 | ||
| VAMP8 | vesicle-associated membrane protein 8 (endobrevin) | 0.011 | ||
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.011 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.011 | ||
| VHL | von Hippel-Lindau tumor suppressor | 0.011 | ||
| LAPTM5 | lysosomal protein transmembrane 5 | 0.011 | ||
| TUBA1A | tubulin, alpha 1a | 0.011 | ||
| HMHA1 | histocompatibility (minor) HA-1 | 0.011 | ||
| ZC3H12A | zinc finger CCCH-type containing 12A | 0.011 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.011 | ||
| MBD1 | methyl-CpG binding domain protein 1 | 0.011 | ||
| ISG20 | interferon stimulated exonuclease gene 20kDa | 0.011 | ||
| EXT2 | exostosin 2 | 0.011 | ||
| ANKRD28 | ankyrin repeat domain 28 | 0.011 | ||
| HRK | harakiri, BCL2 interacting protein (contains only BH3 domain) | 0.011 | ||
| MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0.010 | ||
| MARCO | macrophage receptor with collagenous structure | 0.010 | ||
| GPX4 | glutathione peroxidase 4 (phospholipid hydroperoxidase) | 0.010 | ||
| TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.010 | ||
| FBLN1 | fibulin 1 | 0.010 | ||
| BCL10 | B-cell CLL/lymphoma 10 | 0.010 | ||
| DPT | dermatopontin | 0.010 | ||
| LGALS1 | lectin, galactoside-binding, soluble, 1 | 0.010 | Human |